JIANGXI TIANXIN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.37 CNY | +3.33% |
|
+4.93% | +9.69% |
| Sales 2022 | 2.3B 318M | Sales 2023 | 1.88B 259M | Capitalization | 10.52B 1.45B |
|---|---|---|---|---|---|
| Net income 2022 | 622M 85.7M | Net income 2023 | 476M 65.59M | EV / Sales 2022 | 4.54 x |
| Net cash position 2022 | 2.29B 316M | Net cash position 2023 | 2.2B 303M | EV / Sales 2023 | 4.42 x |
| P/E ratio 2022 |
19.3
x | P/E ratio 2023 |
22.1
x | Employees | 2,471 |
| Yield 2022 |
2.44% | Yield 2023 |
2.08% | Free-Float | 9.09% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.33% | ||
| 1 week | +4.93% | ||
| Current month | +9.74% | ||
| 1 month | +2.49% | ||
| 3 months | +16.63% | ||
| 6 months | +12.79% | ||
| Current year | +9.69% |
1 week
25.26
26.48
1 month
23.6626.48
Current year
19.1328.35
1 year
19.1331.72
3 years
19.1353.11
5 years
19.1353.11
10 years
19.1353.11
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-11 | 26.37 | +3.33% | 1,286,608 |
| 24-07-10 | 25.52 | -1.69% | 946,940 |
| 24-07-09 | 25.96 | +1.60% | 1,078,167 |
| 24-07-08 | 25.55 | -0.12% | 883,500 |
| 24-07-05 | 25.58 | +1.79% | 1,144,350 |
End-of-day quote Shanghai S.E., July 10, 2024
More quotes
JiangXi Tianxin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of monomeric vitamin products. The Company's main products include vitamin B6, vitamin B1, biotin, folic acid, vitamin D3, ascorbyl palmitate, vitamin E powder, etc. Its products are mainly used in the fields of feed, medicine and food. The Company mainly conducts its businesses in domestic and overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +9.69% | 1.53B | |
| +60.25% | 846B | |
| +38.56% | 628B | |
| -4.49% | 360B | |
| +18.30% | 322B | |
| +9.64% | 297B | |
| +14.15% | 240B | |
| +3.11% | 224B | |
| +16.98% | 223B | |
| +12.87% | 173B |
- Stock Market
- Equities
- 603235 Stock
